Tower Research Capital (TRC)’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$64.1K Buy
20,760
+14,275
+220% +$44.1K ﹤0.01% 2753
2025
Q1
$22.6K Sell
6,485
-6,294
-49% -$22K ﹤0.01% 2841
2024
Q4
$41.8K Buy
12,779
+1,900
+17% +$6.21K ﹤0.01% 2668
2024
Q3
$41.9K Sell
10,879
-5,454
-33% -$21K ﹤0.01% 2818
2024
Q2
$50.5K Buy
16,333
+14,474
+779% +$44.7K ﹤0.01% 3094
2024
Q1
$4.8K Sell
1,859
-4,396
-70% -$11.3K ﹤0.01% 4626
2023
Q4
$15.6K Sell
6,255
-3,254
-34% -$8.14K ﹤0.01% 3816
2023
Q3
$19.3K Buy
9,509
+2,397
+34% +$4.87K ﹤0.01% 3411
2023
Q2
$16.4K Sell
7,112
-2,680
-27% -$6.16K ﹤0.01% 3542
2023
Q1
$30K Sell
9,792
-5,026
-34% -$15.4K ﹤0.01% 2980
2022
Q4
$35K Buy
14,818
+4,170
+39% +$9.85K ﹤0.01% 2600
2022
Q3
$21K Sell
10,648
-5,375
-34% -$10.6K ﹤0.01% 3879
2022
Q2
$43K Buy
16,023
+5,450
+52% +$14.6K ﹤0.01% 3030
2022
Q1
$31K Buy
10,573
+5,963
+129% +$17.5K ﹤0.01% 3100
2021
Q4
$17K Sell
4,610
-1,152
-20% -$4.25K ﹤0.01% 3826
2021
Q3
$25K Sell
5,762
-2,844
-33% -$12.3K ﹤0.01% 3508
2021
Q2
$26K Buy
8,606
+4,158
+93% +$12.6K ﹤0.01% 3631
2021
Q1
$15K Sell
4,448
-130
-3% -$438 ﹤0.01% 4088
2020
Q4
$16K Buy
4,578
+175
+4% +$612 ﹤0.01% 3994
2020
Q3
$14K Sell
4,403
-6,941
-61% -$22.1K ﹤0.01% 3954
2020
Q2
$21K Sell
11,344
-899
-7% -$1.66K ﹤0.01% 3644
2020
Q1
$12K Buy
12,243
+12,143
+12,143% +$11.9K ﹤0.01% 1927
2019
Q4
$0 Sell
100
-38,689
-100% ﹤0.01% 3438
2019
Q3
$59K Buy
38,789
+34,005
+711% +$51.7K ﹤0.01% 1669
2019
Q2
$10K Sell
4,784
-2,861
-37% -$5.98K ﹤0.01% 2540
2019
Q1
$28K Sell
7,645
-2,564
-25% -$9.39K ﹤0.01% 2079
2018
Q4
$39K Buy
10,209
+8,647
+554% +$33K ﹤0.01% 1446
2018
Q3
$15K Buy
1,562
+850
+119% +$8.16K ﹤0.01% 2511
2018
Q2
$5K Sell
712
-1,836
-72% -$12.9K ﹤0.01% 3045
2018
Q1
$13K Buy
+2,548
New +$13K ﹤0.01% 2349
2017
Q4
Sell
-8,283
Closed -$51K 3448
2017
Q3
$51K Sell
8,283
-1,943
-19% -$12K ﹤0.01% 1947
2017
Q2
$37K Buy
10,226
+5,377
+111% +$19.5K ﹤0.01% 897
2017
Q1
$16K Sell
4,849
-3,803
-44% -$12.5K ﹤0.01% 1420
2016
Q4
$21K Buy
8,652
+7,180
+488% +$17.4K ﹤0.01% 2076
2016
Q3
$5K Sell
1,472
-810
-35% -$2.75K ﹤0.01% 2516
2016
Q2
$8K Sell
2,282
-3,913
-63% -$13.7K ﹤0.01% 2998
2016
Q1
$25K Sell
6,195
-1,471
-19% -$5.94K ﹤0.01% 1179
2015
Q4
$35K Buy
7,666
+2,366
+45% +$10.8K 0.01% 758
2015
Q3
$32K Hold
5,300
﹤0.01% 1331
2015
Q2
$63K Sell
5,300
-12
-0.2% -$143 0.01% 1183
2015
Q1
$93K Buy
5,312
+4,500
+554% +$78.8K 0.01% 957
2014
Q4
$12K Buy
812
+621
+325% +$9.18K ﹤0.01% 1965
2014
Q3
$4K Sell
191
-546
-74% -$11.4K ﹤0.01% 3396
2014
Q2
$10K Sell
737
-95
-11% -$1.29K ﹤0.01% 2337
2014
Q1
$18K Sell
832
-3,084
-79% -$66.7K ﹤0.01% 1981
2013
Q4
$31K Buy
3,916
+2,631
+205% +$20.8K 0.01% 1839
2013
Q3
$9K Buy
+1,285
New +$9K ﹤0.01% 3258